College of Pharmacy, Wonkwang University, Iksan 54538, Republic of Korea.
College of Medical and Life Sciences, Silla University, Busan 46958, Republic of Korea.
Neurochem Int. 2018 Feb;113:8-22. doi: 10.1016/j.neuint.2017.11.010. Epub 2017 Nov 22.
In the course of searching for anti-neuroinflammatory metabolites from marine-derived fungi, three fungal metabolites, 6,8,1'-tri-O-methylaverantin, 6,8-di-O-methylaverufin, and 5-methoxysterigmatocystin were isolated from a marine-derived fungal strain Aspergillus sp. SF-6796. Among these, 6,8,1'-tri-O-methylaverantin induced the expression of heme oxygenase (HO)-1 protein in BV2 microglial cells. The induction of HO-1 protein was mediated by the activation of nuclear transcription factor erythroid-2 related factor 2 (Nrf2), and was regulated by the p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase/protein kinase B signaling pathways. Furthermore, 6,8,1'-tri-O-methylaverantin suppressed the overproduction of pro-inflammatory mediators, such as nitric oxide, prostaglandin E, inducible nitric oxide synthase, and cyclooxygenase-2 in lipopolysaccharide (LPS)-stimulated BV2 microglial cells. These anti-neuroinflammatory effects were mediated through the negative regulation of the nuclear factor kappa B pathway, repressing the phosphorylation and degradation of inhibitor kappa B-α, translocation into the nucleus of p65/p50 heterodimer, and DNA-binding activity of p65 subunit. The anti-neuroinflammatory effect of 6,8,1'-tri-O-methylaverantin was partially blocked by a selective HO-1 inhibitor, suggesting that its anti-neuroinflammatory effect is at least partly mediated by HO-1 induction. In this study, 6,8,1'-tri-O-methylaverantin also induced HO-1 protein expression in primary microglial cells, and this correlated with anti-neuroinflammatory effects observed in LPS-stimulated primary microglial cells. In conclusion, 6,8,1'-tri-O-methylaverantin represents a potential candidate for use in the development of therapeutic agents for the regulation of neuroinflammation in neurodegenerative diseases.
在从海洋来源的真菌中寻找抗神经炎症代谢产物的过程中,从海洋来源真菌 Aspergillus sp. SF-6796 中分离得到三种真菌代谢产物:6,8,1'-三-O-甲基大黄素,6,8-二-O-甲基大黄素和 5-甲氧基麦角甾酮。其中,6,8,1'-三-O-甲基大黄素可诱导 BV2 小胶质细胞中血红素加氧酶(HO)-1 蛋白的表达。HO-1 蛋白的诱导是通过核转录因子红细胞 2 相关因子 2(Nrf2)的激活介导的,并且受到 p38 丝裂原激活蛋白激酶和磷脂酰肌醇 3-激酶/蛋白激酶 B 信号通路的调节。此外,6,8,1'-三-O-甲基大黄素抑制脂多糖(LPS)刺激的 BV2 小胶质细胞中促炎介质如一氧化氮、前列腺素 E、诱导型一氧化氮合酶和环氧化酶-2 的过度产生。这些抗炎作用是通过核因子 kappa B 途径的负调控介导的,抑制 IκB-α的磷酸化和降解,p65/p50 异二聚体转入核内以及 p65 亚基的 DNA 结合活性。6,8,1'-三-O-甲基大黄素的抗炎作用被选择性 HO-1 抑制剂部分阻断,表明其抗炎作用至少部分通过 HO-1 诱导介导。在这项研究中,6,8,1'-三-O-甲基大黄素还诱导原代小胶质细胞中 HO-1 蛋白的表达,并且与 LPS 刺激的原代小胶质细胞中观察到的抗炎作用相关。总之,6,8,1'-三-O-甲基大黄素代表了一种有潜力的候选物,可用于开发调节神经退行性疾病中神经炎症的治疗剂。